Home 
How Blumble Works 
Search Algorithm 
Your Privacy 
About 
Facebook
Twitter
Blog
cancer
Cancer.gov is an online resource for cancer-related information, provided by the National Cancer Institute (NCI). It provides up-to-date, science-based information on cancer, including prevention and early detection, diagnosis and treatment, and research. The website also contains resources for patients, caregivers, and healthcare professionals, as well as information on clinical trials and research programs. Cancer.gov also provides resources for health professionals, educators, and members of the public health community. Through this website, individuals can learn about the latest developments in cancer, access helpful resources and tools, and stay informed about NCI initiatives and activities.
-
EncryptedSite is Encrypted
-
CountryHosted in United States
-
CityWalkersville, Maryland
-
Latitude\Longitude39.4787 / -77.3484 Google Map
-
Traffic rank#1,490 Site Rank
-
Site Owner informationWhois info
Website is Safe
Site is not blacklisted
Traffic rank
#1,490
#1,490
Site age
Location
United States
United States
Popular Questions for cancer
Newest job postings for cancer
via Nature
schedule_type: Full-time
The National Cancer Institute (NCI) is seeking an outstanding, internationally recognized, and visionary scientist to build and lead a new Center for Cancer Bioengineering (CCBE) in the NCI Center for Cancer Research (CCR). This position is a key component of a major initiative to establish a world-class bioengineering community dedicated to cancer in the Intramural Program at the National... Institutes of Health (NIH). The position is equivalent
The National Cancer Institute (NCI) is seeking an outstanding, internationally recognized, and visionary scientist to build and lead a new Center for Cancer Bioengineering (CCBE) in the NCI Center for Cancer Research (CCR). This position is a key component of a major initiative to establish a world-class bioengineering community dedicated to cancer in the Intramural Program at the National... Institutes of Health (NIH). The position is equivalent to a tenured academic department chair.The successful candidate will provide scientific and administrative leadership to build a new research center that develops and applies engineering principles to address critical problems in the detection, diagnosis, biology, and treatment of cancer. Areas of focus may include, but are not limited to, development of biomaterials, 3D cell and tissue engineering, immunomodulation, synthetic biology, nanoparticles, microfluidics and drug delivery.The inaugural director of the CCBE will define overall scientific strategy and direction of the center through recruitment of junior and senior faculty. The center will be a centerpiece of a growing community of engineers at the NIH, particularly at the NCI, the NIH Clinical Center and the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The center director will have the opportunity to build engineering infrastructure within newly renovated space on our Frederick, MD campus that complements the extensive chemical, structural, imaging, biological and clinical state-of-art technologies that exist within the CCR. The successful applicant will also oversee mentoring and training activities and is responsible for ensuring an inclusive, diverse, collaborative, and healthy work environment. You will be asked to submit a statement with your application that describes specific descriptions of activities including teaching and mentoring, participation on committees or workshops addressing diversity, equity, and inclusion (DEI) issues, and recruitment efforts aimed at DEI.In addition to directing the CCBE, the director will also be appointed as a tenured NIH Senior Investigator and will lead their own individual world-class research program, supported by generous stable resources, including access to a wide range of NCI technology platforms and interdisciplinary collaborations within NCI, as well as at NIH and its Clinical Center.The Center for Cancer Research (CCR) is home to nearly 250 basic and clinical research groups located on two campuses just outside of Washington, D.C. CCR is part of the National Cancer Institute (NCI) and makes up the largest component of the research effort at the National Institutes of Health (NIH). Centrally supported by long-term funding and a culture of complete intellectual freedom, CCR scientists pursue the most important and challenging problems in cancer research. The CCR research portfolio covers the full spectrum of biomedical research, ranging from basic to translational and clinical. The success of CCR is grounded in an exceptionally strong discovery research program that provides the foundation for the seamless translation of insights from bench to bedside, where clinical trials are conducted in the NIH Clinical Center, the world’s largest hospital dedicated to clinical research. For an overview of CCR, please visit http://ccr.cancer.gov/.The successful candidate must have a Ph.D., M.D/Ph.D or equivalent, an established record in bioengineering, demonstrated leadership ability, proven effectiveness in mentoring and must meet the criteria for NIH tenure. This position is located at the Frederick, MD campus.Salary will be commensurate with experience. A full civil service package of benefits (including health insurance, life insurance, and retirement) is available. Candidates may be U.S. citizens, U.S. permanent residents, or eligible for a visa that will enable work in the United States. This position is subject to a background investigation.Interested candidates should submit the following materials:
Letter of interest, including a career synopsis (maximum 2 pages)
Vision statement for developing a new Center of Bioengineering with the CCR (maximum 2 pages)
Statement of research interests (maximum 3 pages)
Statement of Diversity, Equity and Inclusion (DEI) involvement (maximum 2 pages)
Current curriculum vitae (CV) and complete bibliography.
For more information, contact CCR’s Faculty Recruitment Coordinator at hollidal@mail.nih.gov.Applications should be submitted electronically to https://service.cancer.gov/ccr-careers and will be accepted until the position is filled. Review of applications will begin February 15, 2023 Show more details...
Letter of interest, including a career synopsis (maximum 2 pages)
Vision statement for developing a new Center of Bioengineering with the CCR (maximum 2 pages)
Statement of research interests (maximum 3 pages)
Statement of Diversity, Equity and Inclusion (DEI) involvement (maximum 2 pages)
Current curriculum vitae (CV) and complete bibliography.
For more information, contact CCR’s Faculty Recruitment Coordinator at hollidal@mail.nih.gov.Applications should be submitted electronically to https://service.cancer.gov/ccr-careers and will be accepted until the position is filled. Review of applications will begin February 15, 2023 Show more details...
via Science Careers
schedule_type: Full-time
The Center for Immuno-Oncology (CIO) Translational Research area at the National Cancer Institute functions as a multidisciplinary and interdisciplinary translational research programmatic effort with the goal of developing novel immunotherapies and immunotherapeutic strategies for cancer. Focus is placed on the development of novel immunotherapeutics, not only as monotherapies, but more... importantly, in combination with other immune-mediating modalities,
The Center for Immuno-Oncology (CIO) Translational Research area at the National Cancer Institute functions as a multidisciplinary and interdisciplinary translational research programmatic effort with the goal of developing novel immunotherapies and immunotherapeutic strategies for cancer. Focus is placed on the development of novel immunotherapeutics, not only as monotherapies, but more... importantly, in combination with other immune-mediating modalities, and other conventional or experimental therapies, as part of an immuno-oncology programmatic effort. Within this effort are several research groups which interact closely with the clinical groups of the CIO, and with collaborators within the NCI intramural and extramural programs, and with investigators in the private sector. As Co-Director of the CIO, Dr. Jeffrey Schlom directs the Translational Research area of investigation.
The program takes advantage of the uniqueness of the NCI intramural program in that it spans high-risk basic discovery research in immunology genomics and tumor biology, through preclinical translational research, to paradigm-shifting clinical trials. Focus is placed on the design and development of novel 'off-the-shelf' recombinant (rec.) immunotherapeutics that can be used in clinical studies at numerous institutions. A major strength of the program is the rapid translation of preclinical studies to hypothesis-generating clinical trials.
We are looking for post-doctoral fellows interested in learning immunology and immunotherapy. This full-time training position is available immediately. The appointment duration is up to 5 years. The job requires an Ph.D., M.D., or equivalent in immunology, molecular/cell biology or experimental pathology. Stipends are commensurate with education and experience.
Please send a cover letter describing your research experience and interests, CV including bibliography, and contact information for three references to:
Jeffrey Schlom, Ph.D., via e-mail: js141c@nih.gov
Please write "Postdoctoral application" in the subject heading. No calls, please. If we are interested, you will be contacted by Dr. Schlom.
Please refer to the Center for Immuno-Oncology's website
https://ccr.cancer.gov/center-for-immuno-oncology
and Dr. Schlom’s profile page https://ccr.cancer.gov/staff-directory/jeffrey-schlom
to learn more about the CIO and its research.
DHHS, NIH and NCI are equal opportunity employers. The NCI and CCR are deeply committed to diversity of thought, equity and inclusion and encourage applications from qualified women, underrepresented minorities and individuals with disabilities Show more details...
The program takes advantage of the uniqueness of the NCI intramural program in that it spans high-risk basic discovery research in immunology genomics and tumor biology, through preclinical translational research, to paradigm-shifting clinical trials. Focus is placed on the design and development of novel 'off-the-shelf' recombinant (rec.) immunotherapeutics that can be used in clinical studies at numerous institutions. A major strength of the program is the rapid translation of preclinical studies to hypothesis-generating clinical trials.
We are looking for post-doctoral fellows interested in learning immunology and immunotherapy. This full-time training position is available immediately. The appointment duration is up to 5 years. The job requires an Ph.D., M.D., or equivalent in immunology, molecular/cell biology or experimental pathology. Stipends are commensurate with education and experience.
Please send a cover letter describing your research experience and interests, CV including bibliography, and contact information for three references to:
Jeffrey Schlom, Ph.D., via e-mail: js141c@nih.gov
Please write "Postdoctoral application" in the subject heading. No calls, please. If we are interested, you will be contacted by Dr. Schlom.
Please refer to the Center for Immuno-Oncology's website
https://ccr.cancer.gov/center-for-immuno-oncology
and Dr. Schlom’s profile page https://ccr.cancer.gov/staff-directory/jeffrey-schlom
to learn more about the CIO and its research.
DHHS, NIH and NCI are equal opportunity employers. The NCI and CCR are deeply committed to diversity of thought, equity and inclusion and encourage applications from qualified women, underrepresented minorities and individuals with disabilities Show more details...
via JAMA Career Center - JAMA Network
schedule_type: Full-time
MAKE AN IMPACT ON THE DEVELOPMENT OF NOVEL ANTICANCER AGENTS COME TRAIN AT THE NATIONAL CANCER INSTITUTE!
The Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (HHS), is seeking energetic and dedicated candidates for the position of Clinical Fellow/Senior Clinical Fellow in the DCTD... Clinical Oncology Advanced Developmental Therapeutics
MAKE AN IMPACT ON THE DEVELOPMENT OF NOVEL ANTICANCER AGENTS COME TRAIN AT THE NATIONAL CANCER INSTITUTE!
The Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (HHS), is seeking energetic and dedicated candidates for the position of Clinical Fellow/Senior Clinical Fellow in the DCTD... Clinical Oncology Advanced Developmental Therapeutics Training Program (ADTTP). Increased number of novel therapeutic agents and the progressively greater complexity of early clinical trials have led to a need for more physicians with special skills in drug development. The major objective of the ADTTP is to provide medical oncologists advanced training in state-of-the-science principles and technologies of developmental therapeutics by utilizing the unique resources available within the National Cancer Institute (NCI).
The successful candidate(s) will participate in clinical research conducted at the NIH Clinical Center in Bethesda, MD, Developmental Therapeutics Clinic (DTC) (https://dtc.cancer.gov/), NCI. The program will provide an excellent opportunity to refine skills in clinical investigation including novel strategies for trial design and methodology, protocol development, execution, monitoring, conformity with ethical standards, and formulation of attainable and pertinent laboratory correlates.
The trainee(s) will spend 40-60 percent of effort in clinical investigation involving inpatients and outpatients at the NIH, including a minimum of 1.5 days in DTC clinic activities. In addition, the trainee(s) will spend up to 40 percent effort in the DCTD Cancer Therapy Evaluation Program (CTEP) (https://ctep.cancer.gov/). The CTEP component of the training will broaden the trainee’s knowledge of new drug development by providing a unique opportunity to learn principles and concepts of agent prioritization, drug development strategies, protocol development and review, IND requirements, adverse event assessment and reporting.
Candidates must meet all of the following requirements:
•M.D. or an equivalent degree with a license to practice medicine in the United States
•Completion of subspecialty training in Medical Oncology at a US-accredited institution
•Board certification or eligibility in Medical Oncology
A full federal package of benefits (including retirement, leave, health, life, and a 401K equivalent savings plan, etc.) is available. This is a time-limited federal appointment not-to-exceed 2-3 years (there is no assurance of a tenure-track or permanent position with NIH upon completion of the program). Salary is commensurate with experience.
To apply for this position, please submit your Curriculum Vitae; three letters of recommendation (preferably one from the Medical Oncology training program director or supervisor of last professional position); Permanent Residency documentation, if applicable; and personal statement of research goals to: Monika Sarna, DCTD, NCI Administrative Officer (AO) at: msarna@mail.nih.gov. For more information, please contact Alice Chen, M.D. at: alice.chen@nih.gov.
HHS, NIH AND NCI ARE EQUAL OPPORTUNITY EMPLOYERS Show more details...
The Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (HHS), is seeking energetic and dedicated candidates for the position of Clinical Fellow/Senior Clinical Fellow in the DCTD... Clinical Oncology Advanced Developmental Therapeutics Training Program (ADTTP). Increased number of novel therapeutic agents and the progressively greater complexity of early clinical trials have led to a need for more physicians with special skills in drug development. The major objective of the ADTTP is to provide medical oncologists advanced training in state-of-the-science principles and technologies of developmental therapeutics by utilizing the unique resources available within the National Cancer Institute (NCI).
The successful candidate(s) will participate in clinical research conducted at the NIH Clinical Center in Bethesda, MD, Developmental Therapeutics Clinic (DTC) (https://dtc.cancer.gov/), NCI. The program will provide an excellent opportunity to refine skills in clinical investigation including novel strategies for trial design and methodology, protocol development, execution, monitoring, conformity with ethical standards, and formulation of attainable and pertinent laboratory correlates.
The trainee(s) will spend 40-60 percent of effort in clinical investigation involving inpatients and outpatients at the NIH, including a minimum of 1.5 days in DTC clinic activities. In addition, the trainee(s) will spend up to 40 percent effort in the DCTD Cancer Therapy Evaluation Program (CTEP) (https://ctep.cancer.gov/). The CTEP component of the training will broaden the trainee’s knowledge of new drug development by providing a unique opportunity to learn principles and concepts of agent prioritization, drug development strategies, protocol development and review, IND requirements, adverse event assessment and reporting.
Candidates must meet all of the following requirements:
•M.D. or an equivalent degree with a license to practice medicine in the United States
•Completion of subspecialty training in Medical Oncology at a US-accredited institution
•Board certification or eligibility in Medical Oncology
A full federal package of benefits (including retirement, leave, health, life, and a 401K equivalent savings plan, etc.) is available. This is a time-limited federal appointment not-to-exceed 2-3 years (there is no assurance of a tenure-track or permanent position with NIH upon completion of the program). Salary is commensurate with experience.
To apply for this position, please submit your Curriculum Vitae; three letters of recommendation (preferably one from the Medical Oncology training program director or supervisor of last professional position); Permanent Residency documentation, if applicable; and personal statement of research goals to: Monika Sarna, DCTD, NCI Administrative Officer (AO) at: msarna@mail.nih.gov. For more information, please contact Alice Chen, M.D. at: alice.chen@nih.gov.
HHS, NIH AND NCI ARE EQUAL OPPORTUNITY EMPLOYERS Show more details...
Norton safe Web